Detalhe da pesquisa
1.
"Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".
BMC Cancer
; 21(1): 1147, 2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34702204
2.
Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study).
Gynecol Oncol
; 159(1): 256-263, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712155
3.
Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028.
Gynecol Oncol
; 152(2): 243-250, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522700
4.
Non-pegylated liposomal doxorubicin (NPLD, Myocet®)â¯+â¯carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.
Gynecol Oncol
; 152(1): 68-75, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446275
5.
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer.
Int J Gynecol Cancer
; 29(7): 1141-1147, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420414
6.
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Lancet Oncol
; 19(8): 1117-1125, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026000
7.
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
Gynecol Oncol
; 148(1): 36-41, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29107348
8.
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
Qual Life Res
; 27(1): 59-74, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248998
9.
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
Oncologist
; 22(9): 1117-1124, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596446
10.
BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.
Gynecol Oncol
; 140(3): 443-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26740259
11.
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial.
Int J Gynecol Cancer
; 26(5): 898-905, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27206218
12.
Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.
BMC Med Ethics
; 17(1): 63, 2016 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27769273
13.
Survival benefit of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer: a multi-institutional case control study.
Ann Surg Oncol
; 21(11): 3621-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24819120
14.
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
Int J Gynecol Cancer
; 24(9 Suppl 3): S55-60, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341582
15.
Spatial profiling of ovarian carcinoma and tumor microenvironment evolution under neoadjuvant chemotherapy.
Clin Cancer Res
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669064
16.
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
Oncologist
; 18(11): 1190-1, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105751
17.
Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas.
Cancer Res Commun
; 3(5): 830-841, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377900
18.
Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.
Cancers (Basel)
; 14(9)2022 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565475
19.
Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients.
J Surg Oncol
; 103(1): 10-6, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21031424
20.
Pertuzumab for the treatment of breast cancer.
Expert Rev Anticancer Ther
; 20(2): 85-95, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30884986